首页> 外文期刊>Surgical innovation >Feasibility of an Intraluminal Bypass Device in Low Colorectal Anastomosis: Preliminary Results in a Porcine Model
【24h】

Feasibility of an Intraluminal Bypass Device in Low Colorectal Anastomosis: Preliminary Results in a Porcine Model

机译:低结肠直肠吻合术中腔内旁路装置的可行性:猪模型中的初步结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Cologuard CG-100 is a novel intraluminal bypass device designed to reduce the clinical outcomes associated with low colorectal anastomotic leak. The device is inserted transanally, anchored to the colon above the anastomosis, and deployed intraluminally to cover the anastomosis from within. The purpose of this study was to evaluate the safety and performance of the device in a porcine model. Method: Twelve pigs underwent low colorectal anastomosis with insertion of the Cologuard CG-100 device. Contrast material injection, abdominal X-ray, and histologic studies were used to evaluate sealing quality, device positioning, and tissue damage, respectively. The surgeons completed a usability and satisfaction questionnaire after completion of the procedure. Results: Absolute sealing was observed in all 4 animals euthanized immediately after surgery. In the other 8 animals, the device was kept in situ for 10 days and then extracted. X-ray films with injection of contrast material through a designated injection tube before device removal showed that the sheath and ring were correctly placed. No leak was demonstrated. There were no device-related adverse events, and no critical histological abnormalities were noted in the bowel area that was compressed by the device. The device was found to be easy to insert, position, and extract. Conclusion: The Cologuard CG-100 device efficiently reduced contact between fecal content and low colorectal anastomosis in a porcine model and is easily deployed and extracted. It holds promise for possible clinical use pending further studies.
机译:背景:博士劳德CG-100是一种新型的腔内旁路装置,设计用于减少与低结肠直肠吻合泄漏相关的临床结果。该装置经过变性地插入,锚定到吻合术高度以上,并部署在内,以覆盖内部的吻合术。本研究的目的是评估猪模型中器件的安全性和性能。方法:12只猪经历了低结肠直肠吻合,插入博士科CG-100装置。对比材料注射,腹部X射线和组织学研究分别用于评估密封质量,装置定位和组织损伤。外科医生在完成程序后完成了可用性和满意问卷。结果:在手术后立即在所有4只动物中观察到绝对密封。在其他8只动物中,将该装置置于原位10天,然后提取。通过指定的注射管在装置去除之前通过指定的注射管注射X射线薄膜显示鞘和环被正确放置。没有证明泄漏。没有设备相关的不良事件,并且在通过装置压缩的肠道区域中没有注意到的关键组织学异常。发现该装置易于插入,位置和提取。结论:曲酒清CG-100器件在猪模型中有效地降低了粪便含量与低结肠直肠吻合术之间的接触,易于部署和提取。它持有可能临床使用等待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号